Education
About Us
Working with TipRanks
Follow Us
OrganoClick AB (SE:ORGC)
:ORGC
ORGC Stock Chart & Stats
kr1.78
kr0.00(0.00%)
At close: 4:00 PM EST
kr1.78
kr0.00(0.00%)
Day’s Range― - ―
52-Week Rangekr1.21 - kr2.98
Previous CloseN/A
Volume11.05K
Average Volume (3M)87.89K
Market Cap
kr151.25M
Enterprise Valuekr226.36M
Total Cash (Recent Filing)kr2.68M
Total Debt (Recent Filing)kr77.78M
Price to Earnings (P/E)―
Beta0.46
Next Earnings
May 06, 2026EPS Estimate
-0.02Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.10
Shares Outstanding110,003,010
10 Day Avg. Volume18,569
30 Day Avg. Volume87,893
Financial Highlights & Ratios
PEG Ratio-0.05
Price to Book (P/B)11.75
Price to Sales (P/S)1.68
P/FCF Ratio-16.96
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)-0.09
Revenue Forecast (FY)kr121.00M
Bulls Say, Bears Say
Bulls Say
Sustainable Bio-based Platform And Diversified B2B/B2C Revenue ModelOrganoClick's core bio-based chemistry platform and mix of industrial (B2B) and branded consumer (B2C) sales provide durable demand exposure to sustainability trends. This diversification reduces dependence on a single channel and supports multiple routes to scale, licensing, and long-term revenue capture if adoption of greener chemistries continues.
Gross Margin Improved Versus 2022An improvement in gross margin versus 2022 indicates the company has shown progress on product mix, pricing or cost of goods sold. Sustained margin recovery is a structural lever to move toward profitability, enabling better cash conversion and resilience to sales volatility if management preserves cost discipline and scale benefits.
Lean Cost Structure: Small Employee BaseA headcount of 40 signals a lean organization and lower fixed payroll overhead relative to larger chemical peers. That structural cost advantage can extend runway, allow targeted reinvestment in commercial or R&D priorities, and improve operating leverage potential if top-line trends reverse positively without requiring large incremental staffing.
Bears Say
Recurring Losses And Sharply Negative Net MarginPersistent annual losses and a ~-34% net margin in 2025 indicate structural unprofitability. Continued negative margins erode equity, limit reinvestment capacity and force reliance on external funding. Without durable revenue growth or sustained margin recovery, long-term viability and ability to scale commercially are at risk.
Negative Operating Cash Flow And Persistent Free Cash Flow DeficitsNegative operating cash flow in 2025 and persistent negative free cash flow signify structural cash burn. This reduces strategic flexibility, constrains R&D and commercial investments, and increases dependency on financing. Over multiple quarters this elevates liquidity and refinancing risk, particularly in a capital-intensive chemicals context.
Material Increase In Financial Leverage And Capital DestructionA jump to ~6.4x debt/equity and deeply negative ROE reflect shrinking equity and higher debt burdens. Elevated leverage raises fixed interest costs, amplifies downside risk to earnings shocks, and constrains the company's ability to fund growth organically. Capital structure stress limits strategic options and increases default risk in adverse conditions.
OrganoClick AB News
ORGC FAQ
What was OrganoClick AB’s price range in the past 12 months?
OrganoClick AB lowest stock price was kr1.21 and its highest was kr2.98 in the past 12 months.
What is OrganoClick AB’s market cap?
OrganoClick AB’s market cap is kr151.25M.
When is OrganoClick AB’s upcoming earnings report date?
OrganoClick AB’s upcoming earnings report date is May 06, 2026 which is in 43 days.
How were OrganoClick AB’s earnings last quarter?
OrganoClick AB released its earnings results on Feb 12, 2026. The company reported -kr0.1 earnings per share for the quarter, missing the consensus estimate of -kr0.07 by -kr0.03.
Is OrganoClick AB overvalued?
According to Wall Street analysts OrganoClick AB’s price is currently Overvalued.
Does OrganoClick AB pay dividends?
OrganoClick AB does not currently pay dividends.
What is OrganoClick AB’s EPS estimate?
OrganoClick AB’s EPS estimate is -0.02.
How many shares outstanding does OrganoClick AB have?
OrganoClick AB has 110,003,010 shares outstanding.
What happened to OrganoClick AB’s price movement after its last earnings report?
OrganoClick AB reported an EPS of -kr0.1 in its last earnings report, missing expectations of -kr0.07. Following the earnings report the stock price went down -9.639%.
Which hedge fund is a major shareholder of OrganoClick AB?
Currently, no hedge funds are holding shares in SE:ORGC
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
OrganoClick AB
OrganoClick AB (publ), a material and chemical technology company, develops, produces, and markets fiber-based materials and chemicals for treatment of wood, technical textile and nonwoven, and bio composites in Sweden. It offers OrganoWood, a wood preservative technology and wood preservative that gives wood enhanced durability against rot and fire primarily for construction companies and consumers; OrganoTex, a biodegradable durable water repellent technology and textile treatment that makes textile products water repellent, as well as offers shoe and clothes care products; and OrganoComp, a biobased plastic-free and degradable bio-composite used for making 3D-shaped objects that replaces hard plastic materials. The company also provides consumer products, including a range of maintenance and cleaning products for wood, facades, roofs, and terraces, as well as for car care under the BIOkleen name; OC-BioBinder, a biobased, plastic-free, and degradable binder used by industrial customers as a replacement for plastic binders in nonwoven and technical textiles; and OC-AquaSil Tex, a biodegradable hydrophobing product used to replace PFAS in nonwovens, specialty papers, and technical textiles. The company was founded in 2006 and is headquartered in Täby, Sweden.
Technical Analysis
Nexam Chemical Holding AB
―
Svenska Aerogel Holding AB
―
Polygiene AB
―
Impact Coatings AB
―
XP Chemistries AB
―